CHU de Bordeaux
Bordeaux, 33 076, France
NCT Number: NCT03515486
Post-stroke mood disorders (PSMD), including depression, anxiety and apathy, are observed in about 30 % of stroke patients at follow-up 3 or 4 months after stroke occurrence. They impair the functional outcome of the patients and their quality of life. Among the different brain structures involved in PSMD the role of the cerebellum has been under-evaluated while it is now well-known to be involved in mood regulation. The aim of this study will be to describe the characteristics of early and late mood disorders following a first acute ischemic cerebellar stroke using face to face interviews and mobile technologies and investigate their pathophysiological mechanisms through advanced brain Magnetic resonance imaging (MRI) evaluation of cortico-cerebello-cortical morphological and functional connectivity.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Bordeaux, 33 076, France
Stroke is the leading cause of acquired disability in adults. Beyond these physical consequences, stroke is a major cause of mood disorders (depression, anxiety, apathy), affecting more than 30% of patients at 3 months after the initial accident. These mood disorders impair patient's quality of life and their post-stroke functional recovery. Their detection is usually based on an interview conducted during a follow-up visit and intensity is measured through dedicated scales. However the sensitivity of these assessments could be improved by multiple daily ecological assessments carried out in the patient environment through mobile technologies such as smartphones (Experience Sampling Method) and actimeters. Moreover, a better understanding of the pathophysiological mechanisms underlying the presence of post-stroke mood disorders could improve their management. Clinical factors such as the severity of the disability or the female gender are associated with the occurrence of mood disorders but the independent role of the anatomical location of brain injury remains uncertain. During the last decade many studies have suggested the role of the cerebellum in the regulation of cognition and, to a lesser extent, mood. An anatomical or functional impairment of the cortico-cerebellar-cortical loops might contribute to the occurrence of the mood disorders observed in some patients with cerebellar lesion.
The aim of this project is to explore in the context of a cerebellar infarct the transverse association between the presence of post-stroke mood disorders, detected both by standard evaluations and assessments conducted in the ecological environment, and the functional and structural alteration of cortico-cerebellar-cortical loops evaluated by MRI.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each patient will be assessed by a clinical evaluation, will have a standardized psychological evaluation, will perform a brain MRI and will be given a smartphone and an actimeter for a one-week period for the purpose of ecological evaluations
Time frame: Day 0
Evaluation of depressive syndrome defined by a score> 17 for men and> 23 for women according to the CES-D
Time frame: Day 0
Evaluation of anxiety disorder defined by a score> 22 on the BAI scale
Time frame: Day 0
Apathetic syndrome defined by a score > 2 on AI.
Time frame: During 7 days
Evaluation of daily-life mood disorders using one-week Experience Sampling Method (ESM) evaluations (smartphone)
Time frame: During 7 days
Circadian rhythms : sleep fragmentation and relative amplitude of circadian rhythms measured using one-week actimetry.
Time frame: Day 0
Evaluation of emotional dysregulation
Time frame: 24 to 48 months
Evaluation of emotional dysregulation
Time frame: Day 0
Evaluation of emotional dysregulation
Time frame: 24 to 48 months
Evaluation of emotional dysregulation
Time frame: Day 0
Evaluation of emotional dysregulation
Time frame: 24 to 48 months
Evaluation of emotional dysregulation
Time frame: Day 0
Indexes of the structural and functional integrity of emotional regulation networks
Time frame: 24 to 48 months
Evaluation of depressive syndrome defined by a score> 17 for men and> 23 for women according to the CES-D
Time frame: 24 to 48 months
Evaluation of anxiety disorder defined by a score> 22 on the BAI scale
Time frame: 24 to 48 months
Apathetic syndrome defined by a score > 2 on AI.
University Hospital, Bordeaux
Other
Acronym: CERMOOD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04043052
Anxiety Disorders, Behavior
Bordeaux, France
View Trial DetailsNCT06282029
Anxiety, Anxiety Disorders
Bielefeld, Germany
View Trial DetailsNCT03645759
Anxiety, Anxiety Disorders
Houston, Texas, United States
View Trial DetailsNCT03368950
Anxiety Disorders, Behavior
Caterham, Surrey, United Kingdom
View Trial Details